PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite...

23
1

Transcript of PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite...

Page 1: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

1

Page 2: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

2

Page 3: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

3

Page 4: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

4

Page 5: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

5

Page 6: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

6

Page 7: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

7

Page 8: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

8

Page 9: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

9

Page 10: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

10

Page 11: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

11

Page 12: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

12

Page 13: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

13

Page 14: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

14

Page 15: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

15

Page 16: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

16

Page 17: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

17

Page 18: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

18

Page 19: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

19

Page 20: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

20

Page 21: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

21

Page 22: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

22

Page 23: PowerPoint Presentation (EINSTEIN-PEP Apixaban (AMPLIFY)3 Dabigatran (RE-COVER)4 ... tlndefinite therapy is suggested if there is a moderate risk Of bleeding, ...

23


Utah Medicaid Pharmacy and Therapeutics …...Summary: Direct comparisons have not been conducted among dabigatran, desirudin, apixaban, betrixaban, edoxaban, fondaparinux, and rivaroxaban

Utah Medicaid Pharmacy and Therapeutics …...Summary: Direct comparisons have not been conducted among dabigatran, desirudin, apixaban, betrixaban, edoxaban, fondaparinux, and rivaroxaban

Silviu Stanciu Cristina Enciu Medic ia Medicația …cardiorisk.ro/brosuri/Medicatia cardiovasculara.pdfn func #ie de valorile INR-ului, n timp ce pentru Dabigatran, Apixaban, Rivaroxaban

Silviu Stanciu Cristina Enciu Medic ia Medicația …cardiorisk.ro/brosuri/Medicatia cardiovasculara.pdfn func #ie de valorile INR-ului, n timp ce pentru Dabigatran, Apixaban, Rivaroxaban

RESULTADOS ENCUESTA NACIONAL ASHP 2009: … · • Profilaxis PTC/PTR con IR (150mg/24h): Dabigatran • Síndrome coronario agudo: Apixaban ... • almacenaje / seguridad • TIEMPO

RESULTADOS ENCUESTA NACIONAL ASHP 2009: … · • Profilaxis PTC/PTR con IR (150mg/24h): Dabigatran • Síndrome coronario agudo: Apixaban ... • almacenaje / seguridad • TIEMPO

orale directe .pdf · Alte anticoagulante orale directe (apixaban, edoxaban si dabigatran etexilat) pot fi asociate cu un risc similar crescut de evenimente trombotice recurente,

orale directe .pdf · Alte anticoagulante orale directe (apixaban, edoxaban si dabigatran etexilat) pot fi asociate cu un risc similar crescut de evenimente trombotice recurente,

Silviu Stanciu Cristina Enciu Medic ia Medicația ... cardiovasculara.pdf · n func #ie de valorile INR-ului, n timp ce pentru Dabigatran, Apixaban, Rivaroxaban dozele sunt " xe;

Silviu Stanciu Cristina Enciu Medic ia Medicația ... cardiovasculara.pdf · n func #ie de valorile INR-ului, n timp ce pentru Dabigatran, Apixaban, Rivaroxaban dozele sunt " xe;

Rivaroxaban in SPAF - swisscardio.ch · Rivaroxaban in SPAF: Efficacy, safety and cardio-vascular profile Hans Rickli, St.Gallen. ... • Dabigatran and apixaban: evaluated across

Rivaroxaban in SPAF - swisscardio.ch · Rivaroxaban in SPAF: Efficacy, safety and cardio-vascular profile Hans Rickli, St.Gallen. ... • Dabigatran and apixaban: evaluated across

Vorhofflimmern und Blutverdünnung · Vorhofflimmern und Blutverdünnung: Wann Marcumar und wann eine der „neuen Substanzen“? (Dabigatran, Rivaroxaban, Apixaban) • Dabigatranetexilat

Vorhofflimmern und Blutverdünnung · Vorhofflimmern und Blutverdünnung: Wann Marcumar und wann eine der „neuen Substanzen“? (Dabigatran, Rivaroxaban, Apixaban) • Dabigatranetexilat

New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. 2013

New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation. 2013

Actualización del tratamiento - ICSCYL · · 4 fármacos: Dabigatran(II) /Apixaban, Edoxaban, Rivaroxaban(Xa). · Indicados en prevención del ictus y de la embolia sistémica en

Actualización del tratamiento - ICSCYL · · 4 fármacos: Dabigatran(II) /Apixaban, Edoxaban, Rivaroxaban(Xa). · Indicados en prevención del ictus y de la embolia sistémica en

Dabigatran, rivaroxaban and apixaban, the new oral ... · In patients with gastritis, oesophagitis, or gastro-oesophageal reflux, the dose of dabigatran (150mg twice daily or 110mg

Dabigatran, rivaroxaban and apixaban, the new oral ... · In patients with gastritis, oesophagitis, or gastro-oesophageal reflux, the dose of dabigatran (150mg twice daily or 110mg

€¦ · Web viewTo review the predicted versus actual use of the novel oral anticoagulants (NOACs), including apixaban, dabigatran and rivaroxaban, for …

€¦ · Web viewTo review the predicted versus actual use of the novel oral anticoagulants (NOACs), including apixaban, dabigatran and rivaroxaban, for …

1 Año V - Nº 55 – Julio de 2014 - colfarsfe.org.ar · - Anticoagulantes Orales: Apixaban, Dabigatran y Rivaroxaban. Recomendaciones. INVIMA. - Parches transdérmicos de fentanilo:

1 Año V - Nº 55 – Julio de 2014 - colfarsfe.org.ar · - Anticoagulantes Orales: Apixaban, Dabigatran y Rivaroxaban. Recomendaciones. INVIMA. - Parches transdérmicos de fentanilo:

Drug Class Review: Target Specific Oral Anticoagulants ... · Drug Class Review: Target Specific Oral Anticoagulants Dabigatran (Pradaxa), Rivaroxaban (Xarelto), and Apixaban (Eliquis)

Drug Class Review: Target Specific Oral Anticoagulants ... · Drug Class Review: Target Specific Oral Anticoagulants Dabigatran (Pradaxa), Rivaroxaban (Xarelto), and Apixaban (Eliquis)

Nuovi Anticoagulanti Orali - acemc.it · Rivaroxaban nel paziente con Insufficienza Renale ... Il tromboembolismo venoso. Dabigatran Rivaroxaban Apixaban STUDIO RECOVER (NEJM 2009)

Nuovi Anticoagulanti Orali - acemc.it · Rivaroxaban nel paziente con Insufficienza Renale ... Il tromboembolismo venoso. Dabigatran Rivaroxaban Apixaban STUDIO RECOVER (NEJM 2009)

Open Access Research Evolving landscape of stroke ... · tamin K antagonist oral anticoagulants (Novel Oral ACs (NOACs) such as dabigatran, apixaban and rivaroxaban) was recommended

Open Access Research Evolving landscape of stroke ... · tamin K antagonist oral anticoagulants (Novel Oral ACs (NOACs) such as dabigatran, apixaban and rivaroxaban) was recommended

Patient Education Toolkit Newer Anticoagulants · 2017-03-29 · Newer Anticoagulants Coumadin®(warfarin), Eliquis® ( apixaban), Pradaxa® (dabigatran), Xarelto® (rivaroxaban)

Patient Education Toolkit Newer Anticoagulants · 2017-03-29 · Newer Anticoagulants Coumadin®(warfarin), Eliquis® ( apixaban), Pradaxa® (dabigatran), Xarelto® (rivaroxaban)

Anticoagulation and New Anticoagulants Final - Handout.ppt · Antidote Yes No - except for dabigatran Direct oral anticoagulants (DOACs) Dabigatran Rivaroxaban Apixaban Edoxaban Mechanism

Anticoagulation and New Anticoagulants Final - Handout.ppt · Antidote Yes No - except for dabigatran Direct oral anticoagulants (DOACs) Dabigatran Rivaroxaban Apixaban Edoxaban Mechanism

A Comparative Evaluation of Adverse Drug Events and ...€¦ · with dabigatran and rivaroxaban use. Apixaban was excluded due to a small sample size. Secondary outcomes included

A Comparative Evaluation of Adverse Drug Events and ...€¦ · with dabigatran and rivaroxaban use. Apixaban was excluded due to a small sample size. Secondary outcomes included

Direct Oral Anticoagulants - SOCHIHEM · Direct Oral Anticoagulants Dabigatran etexilate Rivaroxaban Apixaban Edoxaban Target Thrombin Factor Xa Factor Xa Factor Xa Bioavailability

Direct Oral Anticoagulants - SOCHIHEM · Direct Oral Anticoagulants Dabigatran etexilate Rivaroxaban Apixaban Edoxaban Target Thrombin Factor Xa Factor Xa Factor Xa Bioavailability

Representativeness of the Dabigatran, Apixaban and Rivaroxaban

Representativeness of the Dabigatran, Apixaban and Rivaroxaban